Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objective This study evaluated the diagnostic utility of novel parameters derived from complete blood count (CBC) analysis, including the nucleated red blood cell count (NRBC), neutrophil-to-lymphocyte ratio (NLR), red cell distribution width (RDW), plateletcrit (PCT), and platelet-to-lymphocyte ratio (PLR), in identifying late-onset neonatal sepsis (LOS). Methods This was a retrospective, single-center, case‒control study in a tertiary neonatal intensive care unit. The study included 38 neonates diagnosed with LOS and 22 healthy control subjects. The data collected included demographic characteristics, clinical findings, and laboratory values, including CBC-derived parameters, C-reactive protein (CRP) levels, and blood cultures. Statistical analyses were performed to assess differences between groups and the diagnostic performance of key parameters via receiver operating characteristic (ROC) curves. Results Significant differences in multiple parameters were observed between the LOS and control groups. Elevated CRP, platelet count, PCT, lymphocyte percentage, and PLR, in addition to decreased hemoglobin, hematocrit, neutrophil percentage, NRBC percentage, and NLR, were associated with LOS. PLR demonstrated the strongest diagnostic utility, with a cutoff value of 45.24 achieving 81.6% sensitivity, 61.9% specificity, and an area under the curve (AUC) of 0.787 (95% CI: 0.671–0.903). Logistic regression analysis revealed that the PLR was the most significant independent predictor of LOS (OR: 1.071; 95% CI: 1.009–1.135, p = 0.023). Conclusion CBC-derived parameters, particularly the PLR, offer promising diagnostic value for LOS. These findings support incorporating these accessible and cost-effective biomarkers into clinical practice for the early diagnosis and management of LOS, warranting further validation in larger, multicenter studies.
Objective This study evaluated the diagnostic utility of novel parameters derived from complete blood count (CBC) analysis, including the nucleated red blood cell count (NRBC), neutrophil-to-lymphocyte ratio (NLR), red cell distribution width (RDW), plateletcrit (PCT), and platelet-to-lymphocyte ratio (PLR), in identifying late-onset neonatal sepsis (LOS). Methods This was a retrospective, single-center, case‒control study in a tertiary neonatal intensive care unit. The study included 38 neonates diagnosed with LOS and 22 healthy control subjects. The data collected included demographic characteristics, clinical findings, and laboratory values, including CBC-derived parameters, C-reactive protein (CRP) levels, and blood cultures. Statistical analyses were performed to assess differences between groups and the diagnostic performance of key parameters via receiver operating characteristic (ROC) curves. Results Significant differences in multiple parameters were observed between the LOS and control groups. Elevated CRP, platelet count, PCT, lymphocyte percentage, and PLR, in addition to decreased hemoglobin, hematocrit, neutrophil percentage, NRBC percentage, and NLR, were associated with LOS. PLR demonstrated the strongest diagnostic utility, with a cutoff value of 45.24 achieving 81.6% sensitivity, 61.9% specificity, and an area under the curve (AUC) of 0.787 (95% CI: 0.671–0.903). Logistic regression analysis revealed that the PLR was the most significant independent predictor of LOS (OR: 1.071; 95% CI: 1.009–1.135, p = 0.023). Conclusion CBC-derived parameters, particularly the PLR, offer promising diagnostic value for LOS. These findings support incorporating these accessible and cost-effective biomarkers into clinical practice for the early diagnosis and management of LOS, warranting further validation in larger, multicenter studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.